Hair transplant after cancer: when can it be considered?

Allowing time for hair to regrow after chemotherapy

Some chemotherapy drugs affect the rapidly dividing cells that produce hair. Hair loss can involve the scalp, eyebrows, eyelashes and body hair. Its extent depends on the drugs and treatment schedule; not every cancer treatment causes complete hair loss.

Hair often starts growing again after chemotherapy finishes. The National Cancer Institute gives two to three months as a common starting point, with a different texture or colour sometimes appearing at first. Fine new growth is not yet the same as recovering your previous length and volume. Individual recovery varies. National Cancer Institute, 2020

Planning surgery in the first few weeks without visible growth would therefore be premature. Photographs taken under similar lighting and follow-up appointments are more useful for assessing progress than checking for changes every day.

Persistent alopecia does not always mean complete, irreversible loss

Absent or incomplete regrowth more than six months after chemotherapy is generally described as persistent chemotherapy-induced alopecia. This describes a prolonged problem; it does not establish that every follicle has been destroyed or that no treatment can help. Hair may be diffusely thin or follow a pattern resembling androgenetic hair loss. Freites-Martinez et al., 2019

A prospective study published in 2019 followed 61 women receiving chemotherapy for breast cancer at one Korean centre. It documented lasting changes in hair density or thickness, with a stronger association in women receiving taxane-containing regimens. These findings cannot be used as the personal risk of permanent hair loss after any cancer treatment. Thinner individual hairs also do not mean that no regrowth has occurred. Kang et al., 2019

Assessing the scalp after radiotherapy

Radiotherapy can cause hair loss in the area exposed to radiation. Treatment away from the scalp therefore has different implications from cranial radiotherapy. Regrowth may occur over the following months. The National Cancer Institute gives three to six months as a common timeframe, while explaining that high doses can leave hair thinner or prevent regrowth in the treated area. National Cancer Institute, 2020

The dose actually reaching the scalp, its distribution and other treatments matter. A single total-dose figure on a treatment summary cannot tell you whether your hair will return. Your radiation oncology team can explain which areas were exposed, while a dermatologist examines the remaining follicles and skin.

An irradiated area is not automatically a scar with no remaining potential for hair growth. Some patients have a combination of finer hairs and skin changes; others have more extensive scarring damage. That distinction affects the available options, including whether medical treatment might help. Phillips et al., 2020

What needs checking before a hair transplant?

The assessment should answer two separate questions: why is the hair still missing, and would surgery offer a reasonable benefit? Being well enough for an operation does not establish that there is a usable donor area. Equally, thick hair at the back of the head does not establish that surgery is medically appropriate.

Identifying all the causes of thinning

A dermatologist examines your scalp and may use trichoscopy, which provides a magnified view of the hairs and skin. Depending on the findings, they may investigate another contributing cause, such as thyroid disease, a deficiency, pre-existing pattern hair loss or an ongoing medicine. Endocrine therapy for cancer can contribute to thinning without causing the same abrupt shedding as chemotherapy. Memorial Sloan Kettering Cancer Center, 2024

The timeline is useful: what your hair looked like before cancer, when shedding began, which treatments you received, whether regrowth started and what has changed recently. Older photographs may help distinguish a new problem from hair loss that was already developing.

Examining the donor and recipient areas

A transplant redistributes existing follicles. There must be sufficiently healthy hair in a suitable hair transplant donor area, usually the back and sides of the scalp. If diffuse thinning also affects those areas, harvesting may be limited or inappropriate.

The surgeon must assess the recipient skin, including damage from radiation or previous scalp surgery. Significantly altered tissue can make graft growth uncertain or rule out transplantation. The decision depends on the condition of the skin as well as the size of the area you want covered. Evidence on surgical restoration after cancer remains limited. Freites-Martinez et al., 2019

How long should you wait after cancer treatment?

There is no single one-year or two-year waiting period that makes surgery suitable for everyone. Completing chemotherapy, achieving stable cancer control, continuing maintenance treatment and reaching stable hair regrowth are different milestones. The passage of time alone is not medical clearance.

Memorial Sloan Kettering Cancer Center advises against transplantation during chemotherapy and recommends waiting until chemotherapy is complete and regrowth can be assessed. Beyond that, timing needs discussion with the clinicians who know your history. Memorial Sloan Kettering Cancer Center, 2024

Before that discussion, gather relevant treatment summaries, treatment dates, your current medicines and any available information on cranial radiotherapy. Ask what needs checking before elective surgery and when the situation should be reassessed if an operation would currently be premature.

Do not stop cancer medicines or endocrine therapy to make a hair transplant possible. Any change belongs with the team prescribing that treatment. Hair restoration should fit around your cancer care, with communication between your oncologist, dermatologist and surgeon.

What if regrowth remains unsatisfactory?

A treatment such as minoxidil may be discussed after assessing the diagnosis and your other medicines. It is not automatically suitable for everyone and cannot recreate a completely destroyed follicle. Much of the evidence after cancer comes from patient series, so complete recovery cannot be promised. Oral medicines and treatments with hormonal effects require a specific assessment. Freites-Martinez et al., 2019

A wig, hairpiece, a different hairstyle or camouflage can also address an immediate concern. These can be temporary options while the situation develops or long-term choices in their own right. The emotional effect of hair loss deserves attention even when other people see the thinning as minor.

What do transplant results after radiation show?

In the study by Phillips and colleagues, all 71 participants already had persistent radiation-induced alopecia. Only two received a hair transplant: one had a partial response and one a complete response under the study’s criteria. A third patient underwent scalp expansion and plastic surgical reconstruction, a different procedure. These observations show a possibility for selected patients, not a general success rate. Phillips et al., 2020

The names FUE, DHI and Sapphire do not guarantee a result in irradiated skin. Before deciding, ask the surgeon to explain the realistic coverage, donor limitations, uncertainties about healing and what would happen if growth proved insufficient.

Preparing an assessment with Body Expert

Body Expert is a medical tourism agency that supports patients receiving care through partner clinics. If you are considering a hair transplant in Turkey, disclose your cancer history and current treatments from the first enquiry so the medical team can consider the relevant information.

The useful first step is to establish whether a surgical assessment is appropriate. Photographs can inform that conversation, but cannot fully assess irradiated skin or establish that an operation is safe. The outcome may be a recommendation for further local assessment, more time, a different treatment or a transplant with clearly defined limits and expectations.

Sources

Freites-Martinez, A., Shapiro, J., van den Hurk, C., Goldfarb, S., Jimenez, J. J., Rossi, A. M., Paus, R., & Lacouture, M. E. (2019). Persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, and hair growth disorders related to endocrine therapy or cancer surgery. Journal of the American Academy of Dermatology, 80(5), 1199–1213. https://doi.org/10.1016/j.jaad.2018.03.056

Kang, D., Kim, I. R., Choi, E. K., Im, Y. H., Park, Y. H., Ahn, J. S., Lee, J. E., Nam, S. J., Lee, H. K., Park, J. H., Lee, D. Y., Lacouture, M. E., Guallar, E., & Cho, J. (2019). Permanent chemotherapy-induced alopecia in patients with breast cancer: A 3-year prospective cohort study. The Oncologist, 24(3), 414–420. https://doi.org/10.1634/theoncologist.2018-0184

Memorial Sloan Kettering Cancer Center. (2024, November 19). Hair loss and your cancer treatment. https://www.mskcc.org/cancer-care/patient-education/hair-loss-cancer-treatment

National Cancer Institute. (2020, January 15). Hair loss (alopecia) and cancer treatment. https://www.cancer.gov/about-cancer/treatment/side-effects/hair-loss

Phillips, G. S., Freret, M. E., Friedman, D. N., Trelles, S., Kukoyi, O., Freites-Martinez, A., Unger, R. H., Disa, J. J., Wexler, L. H., Tinkle, C. L., Mechalakos, J. G., Dusza, S. W., Beal, K., Wolden, S. L., & Lacouture, M. E. (2020). Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatology, 156(9), 963–972. https://doi.org/10.1001/jamadermatol.2020.2127